Resilience and Equity in Aging, Cancer, and Health (REACH)

Recruiting

Resilience and Equity in Aging, Cancer, and Health (REACH): Promoting Physical Resilience and Cancer Care Equity for Adults Age 65 and Older Diagnosed With Gastrointestinal Malignancy

Who can join

Ages 65 and older · All sexes

Full eligibility criteria

Inclusion Criteria:

* Patients who are age 65+ at time of initial consult at DF/BWCC
* Diagnosed with a gastrointestinal cancer, including: cancers of the esophagus, stomach, pancreas, liver, bile duct, ampulla, colon, rectum, or anus, as well as neuroendocrine tumors.
* Continuing care at DF/BWCC beyond initial consult visit

Exclusion Criteria:

* Patients less than age 65 at time of initial consultation appointment with DF/BWCC.
* Patients who are not continuing care at DF/BWCC beyond first consult visit.
* Not proficient in English, Spanish, Haitian Creole, Portuguese, Traditional Chinese, Arabic, or Russian
* Patient who are not considered appropriate for enrollment due to complex medical, social, or other situation as determined by their primary oncology team.
* Participants with psychiatric illness/social situations that would limit compliance with study requirements.

About the study

The purpose of this multi-phase research study is to understand how consultation of cancer care with a geriatrician can best improve outcomes for older adults with gastrointestinal malignancies.

What is being tested

Phase 2 Intervention - Geriatric Co-Management (other)

Sponsor: Dana-Farber Cancer Institute · Participants: 147 · Started: Jan 18, 2022

Contact the study team

Nadine A Jackson, MD, MPH · Phone: 877-442-3324
Nadine J McCleary, MD, MPH · Phone: 877-442-3324

Official record on ClinicalTrials.gov — NCT04674267

Locations in the U.S.

Massachusetts

Dana-Farber Cancer Institute, Boston

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.